Related Experiment Video
Updated: Jul 16, 2026
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models
Theodora M Steindl1, Daniela Schuster, Christian Laggner
1Institute of Pharmacy, Computer Aided Molecular Design Group, University of Innsbruck, Innrain 52c and Center for Molecular Biosciences Innsbruck (CMBI), Peter-Mair-Strasse 1, A-6020 Innsbruck, Austria. theodora.steindl@uibk.ac.at
This study demonstrates parallel screening, an in silico method, effectively identifies active compounds by screening against multiple pharmacophore models. The platform successfully differentiates similar molecules and retrieves known active ligands with high accuracy.
Area of Science:
- Computational chemistry and drug discovery.
- Bioinformatics and cheminformatics.
- Pharmacophore modeling and virtual screening.
Background:
- Parallel screening is an in silico approach to predict compound biological activity using numerous pharmacophore models.
- Virtual activity profiling enables large-scale compound analysis.
- Differentiating similar molecules and related protein targets is a key challenge in virtual screening.
Purpose of the Study:
- To present an early application of a Pipeline Pilot-based platform for automated, large-scale virtual activity profiling.
- To evaluate the efficacy of parallel screening in identifying active compounds against HIV protease inhibitors.
- To assess the system's ability to distinguish between similar molecules and related protease inhibitors.
Main Methods:
- Utilized a Pipeline Pilot platform for automated virtual screening.
- Employed an extensive set of HIV protease inhibitor pharmacophore models.
- Screened active, inactive, and other protease inhibitors (including aspartic protease inhibitors) against the models.
Main Results:
- The parallel screening system demonstrated a high retrieval rate for known active ligands.
- General protease inhibitors were recovered to a lesser extent than active ligands.
- Inactive compounds showed the lowest recovery rate, indicating good specificity.
Conclusions:
- Parallel screening is a viable in silico method for large-scale virtual activity profiling.
- The platform effectively differentiates between similar molecules and related protein targets.
- This approach shows promise for efficient drug discovery and lead identification.
